Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:II-45-II-49
doi: 10.1161/01.CIR.0000138316.24048.08
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pan, W.
Right arrow Articles by Collard, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pan, W.
Right arrow Articles by Collard, C. D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Coronary Artery Bypass Surgery
*Statins
Related Collections
Right arrow Lipids
Right arrow Cardiovascular Pharmacology
Right arrow Secondary prevention
Right arrow Acute coronary syndromes
Right arrow CV surgery: coronary artery disease

(Circulation. 2004;110:II-45 – II-49.)
© 2004 American Heart Association, Inc.


Surgery for Coronary Artery Disease

Statins Are Associated With a Reduced Incidence of Perioperative Mortality After Coronary Artery Bypass Graft Surgery

Wei Pan, MD; Tatjana Pintar, MD; James Anton, MD; Vei-Vei Lee, MS; William K. Vaughn, PhD; Charles D. Collard, MD

From the Division of Cardiovascular Anesthesiology (W.P., T.P., J.A., C.D.C.) and Division of Biostatistics and Epidemiology (V.-V.L., W.K.V.), Texas Heart Institute, St. Luke’s Episcopal Hospital, Houston, Tex.

Correspondence to Charles D. Collard, MD, Clinical Associate Professor of Anesthesiology, Division of Cardiovascular Anesthesiology, Texas Heart Institute, St. Luke’s Episcopal Hospital, 6720 Bertner Ave, Houston, TX 77030. E-mail ccollard{at}heart.thi.tmc.edu

Background— Statin therapy in nonsurgical patient populations is associated with a significant reduction in adverse cardiovascular events, including death, myocardial infarction (MI), and stroke. Recently, statin therapy was shown to be associated with a reduced incidence of postoperative mortality in patients undergoing major noncardiac vascular surgery. We investigated the influence of preoperative statin therapy on adverse outcomes after primary coronary artery bypass graft (CABG) surgery.

Methods and Results— A retrospective cohort study of patients undergoing primary CABG surgery with cardiopulmonary bypass (CPB) (n=1663) between January 1, 2000 and December 31, 2001 at the Texas Heart Institute was performed. Patients were classified into 2 groups: patients receiving preoperative statin therapy (n=943) and patients not receiving preoperative antihyperlipidemic therapy (n=720). To determine if preoperative statin therapy was independently associated with a reduction in the risk of adverse postoperative outcomes, multivariate stepwise logistic regression was performed controlling for patient demographics, medical history, and preoperative medications. Multivariate logistic regression analysis demonstrated that preoperative statin therapy was independently associated with a significant reduction ({approx}50%) in the risk of 30-day all-cause mortality (3.75% versus 1.80%; P<0.05). The adjusted odds ratio for early mortality in patients receiving preoperative statin therapy compared with patients not receiving antihyperlipidemic agents was 0.53 (95% CI, 0.28 to 0.99). Statin therapy was not independently associated with a reduced risk of postoperative MI, cardiac arrhythmias, stroke, or renal dysfunction. In an attempt to further control for selection bias related to the choice of therapy, multivariate analysis of a propensity-matched cohort of 1362 patients revealed that preoperative statin therapy was independently associated with a significant reduction in the composite endpoint of 30-day all-cause mortality and stroke (7.1% versus 4.6%; P<0.05).

Conclusions— Preoperative statin therapy may reduce the risk of early mortality after primary CABG surgery with CPB.


Key Words: surgery • cardiopulmonary bypass • inflammation • coronary disease • prevention




This article has been cited by other articles:


Home page
CirculationHome page
A. Kulik, M. A. Brookhart, R. Levin, M. Ruel, D. H. Solomon, and N. K. Choudhry
Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
Circulation, October 28, 2008; 118(18): 1785 - 1792.
[Abstract] [Full Text] [PDF]